0001209191-16-126649.txt : 20160608 0001209191-16-126649.hdr.sgml : 20160608 20160608190236 ACCESSION NUMBER: 0001209191-16-126649 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160606 FILED AS OF DATE: 20160608 DATE AS OF CHANGE: 20160608 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pacira Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001396814 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510619477 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: 973-254-3560 MAIL ADDRESS: STREET 1: 5 SYLVAN WAY STREET 2: SUITE 300 CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: PACIRA INC DATE OF NAME CHANGE: 20080318 FORMER COMPANY: FORMER CONFORMED NAME: Blue Acquisition Corp DATE OF NAME CHANGE: 20070418 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HASTINGS PAUL J CENTRAL INDEX KEY: 0001309702 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35060 FILM NUMBER: 161704580 MAIL ADDRESS: STREET 1: 61 HARTFORD STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94114 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-06 0 0001396814 Pacira Pharmaceuticals, Inc. PCRX 0001309702 HASTINGS PAUL J C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY NJ 07054 1 0 0 0 Common Stock 2016-06-06 4 S 0 1136 46.95 D 1717 D The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units. /s/ James Scibetta, Attorney-in-Fact 2016-06-08